KKR Injects Cash And Expertise Into Healthcare Tech Company Infinx
Portfolio Pulse from Lekha Gupta
KKR & Co. Inc. (NYSE: KKR) has acquired a significant minority stake in Infinx, a healthcare tech company specializing in revenue cycle management solutions. The investment aims to leverage KKR's expertise to drive Infinx's growth and aid in bolt-on acquisitions. Norwest Venture Partners also participated in the transaction. KKR's cash and investments stood at $14.6 billion as of the first quarter-end. Investors can gain exposure to KKR through Northern Lights Fund Trust IV FMC Excelsior Focus Equity ETF (NYSE: FMCX) and EA Series Trust WHITEWOLF Publicly Listed Private Equity ETF (BATS: LBO).
May 21, 2024 | 1:57 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Investors can gain exposure to KKR's recent acquisition of Infinx through the Northern Lights Fund Trust IV FMC Excelsior Focus Equity ETF.
FMCX holds KKR shares, and the positive impact on KKR's stock price due to the Infinx acquisition could benefit FMCX ETF holders.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 50
POSITIVE IMPACT
KKR has acquired a significant minority stake in Infinx, aiming to leverage its expertise to drive growth and aid in bolt-on acquisitions.
The acquisition of a significant minority stake in Infinx is likely to positively impact KKR's stock price in the short term due to the potential for growth and expansion in the healthcare tech sector.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Investors can gain exposure to KKR's recent acquisition of Infinx through the EA Series Trust WHITEWOLF Publicly Listed Private Equity ETF.
LBO holds KKR shares, and the positive impact on KKR's stock price due to the Infinx acquisition could benefit LBO ETF holders.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 50